# Celanese Corp: filings

CE · NYSE · CIK 1306830 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ce.md) · [Financials](/companies/ce/financials.md) · [Filings](/companies/ce/filings.md) · [Insiders](/companies/ce/insiders.md)

## Reports and events: 418 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 1050, 8-K 319, SC 13G/A 73, 10-Q 53, 3 41, DEFA14A 25, UPLOAD 23, DEF 14A 20, 424B2 19, SC 13G 19, 10-K 18, 11-K 18, CORRESP 18, FWP 15, SD 13, 424B5 12, SCHEDULE 13G/A 11, ARS 8, 4/A 7, 8-A12B 7, 8-K/A 7, S-8 7, S-3ASR 6, 144 5, 25-NSE 5, PRE 14A 5, SCHEDULE 13G 5, CERT 4, 5 3, S-8 POS 3, 305B2 2, CERTNYS 2, 10-K/A 1, 144/A 1, 15-12B 1, 424B3 1, 8-A12B/A 1, ARS/A 1, CT ORDER 1, DEFR14A 1, EFFECT 1, POSASR 1, S-4 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-20 | 20:27 ET | [8-K/A](/filings/0001306830-26-000124.md) | 5.02 Departure or appointment of officers or directors | 0001306830-26-000124 |
| 2026-09-16 | 21:00 ET | [8-K](/filings/0001306830-26-000119.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001306830-26-000119 |
| 2026-08-05 | 20:22 ET | [10-Q](/filings/0001306830-26-000117.md) | Quarterly report, period 2026-06-30 | 0001306830-26-000117 |
| 2026-08-04 | 20:23 ET | [8-K](/filings/0001306830-26-000114.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001306830-26-000114 |
| 2026-08-04 | 20:20 ET | [8-K](/filings/0001306830-26-000113.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001306830-26-000113 |
| 2026-08-04 | 20:05 ET | [8-K](/filings/0001104659-26-090359.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-26-090359 |
| 2026-06-10 | 12:00 ET | [8-K](/filings/0001104659-26-072110.md) | 8.01 Other events | 0001104659-26-072110 |
| 2026-05-06 | 20:11 ET | [10-Q](/filings/0001306830-26-000096.md) | Quarterly report, period 2026-03-31 | 0001306830-26-000096 |
| 2026-05-05 | 20:31 ET | [8-K](/filings/0001306830-26-000093.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001306830-26-000093 |
| 2026-05-05 | 20:24 ET | [8-K](/filings/0001306830-26-000091.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001306830-26-000091 |
| 2026-04-20 | 20:22 ET | [8-K](/filings/0001306830-26-000072.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001306830-26-000072 |
| 2026-04-17 | 20:31 ET | [8-K](/filings/0001306830-26-000070.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001306830-26-000070 |
| 2026-03-04 | 21:15 ET | [DEF 14A](/filings/0001306830-26-000052.md) | Proxy statement, period 2026-04-16 | 0001306830-26-000052 |
| 2026-03-04 | 12:43 ET | [8-K](/filings/0001306830-26-000046.md) | 5.02 Departure or appointment of officers or directors | 0001306830-26-000046 |
| 2026-02-24 | 21:35 ET | [10-K](/filings/0001306830-26-000031.md) | Annual report, period 2025-12-31 | 0001306830-26-000031 |
| 2026-02-17 | 21:54 ET | [8-K](/filings/0001306830-26-000017.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001306830-26-000017 |
| 2026-02-17 | 21:49 ET | [8-K](/filings/0001306830-26-000016.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001306830-26-000016 |
| 2026-01-06 | 21:50 ET | [8-K](/filings/0001306830-26-000003.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001306830-26-000003 |
| 2025-12-17 | 21:09 ET | [8-K](/filings/0001628280-25-057638.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001628280-25-057638 |
| 2025-12-16 | 13:30 ET | [8-K](/filings/0001628280-25-057235.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-057235 |
| 2025-12-04 | 21:30 ET | [8-K](/filings/0001628280-25-055376.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001628280-25-055376 |
| 2025-12-02 | 12:26 ET | [8-K](/filings/0001628280-25-054601.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-054601 |
| 2025-11-07 | 21:41 ET | [10-Q](/filings/0001306830-25-000225.md) | Quarterly report, period 2025-09-30 | 0001306830-25-000225 |
| 2025-11-06 | 21:57 ET | [8-K](/filings/0001306830-25-000221.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001306830-25-000221 |
| 2025-11-06 | 21:25 ET | [8-K](/filings/0001306830-25-000217.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001306830-25-000217 |
| 2025-10-28 | 20:42 ET | [8-K](/filings/0001306830-25-000205.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001306830-25-000205 |
| 2025-10-28 | 13:03 ET | [8-K](/filings/0001306830-25-000203.md) | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001306830-25-000203 |
| 2025-08-11 | 21:30 ET | [8-K](/filings/0001104659-25-076253.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-25-076253 |
| 2025-08-11 | 20:36 ET | [10-Q](/filings/0001306830-25-000174.md) | Quarterly report, period 2025-06-30 | 0001306830-25-000174 |
| 2025-08-11 | 20:27 ET | [8-K](/filings/0001306830-25-000173.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001306830-25-000173 |
| 2025-08-11 | 20:16 ET | [8-K](/filings/0001306830-25-000171.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001306830-25-000171 |
| 2025-05-16 | 01:00 ET | [8-K](/filings/0001104659-25-049701.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-25-049701 |
| 2025-05-06 | 20:12 ET | [10-Q](/filings/0001306830-25-000105.md) | Quarterly report, period 2025-03-31 | 0001306830-25-000105 |
| 2025-05-05 | 21:15 ET | [8-K](/filings/0001306830-25-000102.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001306830-25-000102 |
| 2025-05-05 | 21:06 ET | [8-K](/filings/0001306830-25-000100.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001306830-25-000100 |
| 2025-03-24 | 12:49 ET | [DEF 14A](/filings/0001306830-25-000083.md) | Proxy statement, period 2025-05-14 | 0001306830-25-000083 |
| 2025-03-19 | 20:54 ET | [8-K](/filings/0001628280-25-013866.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-013866 |
| 2025-03-14 | 21:29 ET | [8-K](/filings/0001104659-25-024036.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-25-024036 |
| 2025-03-14 | 20:03 ET | [8-K](/filings/0001628280-25-012811.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001628280-25-012811 |
| 2025-03-07 | 22:22 ET | [8-K](/filings/0001628280-25-011374.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001628280-25-011374 |
| 2025-03-05 | 12:29 ET | [8-K](/filings/0001628280-25-010256.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-010256 |
| 2025-02-21 | 21:06 ET | [10-K](/filings/0001306830-25-000027.md) | Annual report, period 2024-12-31 | 0001306830-25-000027 |
| 2025-02-18 | 21:44 ET | [8-K](/filings/0001306830-25-000013.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001306830-25-000013 |
| 2025-02-18 | 21:36 ET | [8-K](/filings/0001306830-25-000012.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001306830-25-000012 |
| 2025-02-18 | 21:07 ET | [8-K](/filings/0001104659-25-014755.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-25-014755 |
| 2025-02-14 | 14:19 ET | [8-K](/filings/0001104659-25-013554.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-013554 |
| 2025-01-16 | 21:19 ET | [8-K](/filings/0001104659-25-004122.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-004122 |
| 2024-12-19 | 21:12 ET | [8-K](/filings/0001306830-24-000197.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001306830-24-000197 |
| 2024-12-12 | 21:15 ET | [8-K](/filings/0001104659-24-128023.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-128023 |
| 2024-12-09 | 21:24 ET | [8-K](/filings/0001104659-24-126774.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-126774 |

Page 1 of 9. [Older](/companies/ce/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:11 ET. No prices; not investment advice.